The STOXX 600 Europe Basic Resources Index includes the 31 most important stocks of the Commodity sector in Europe. Since the gradual reversal from the threshold at 450 points, the Index presents, in the medium-term, a bullish trend as evidenced by the orientation of the 100-day moving average. However, the bearish correction initiated following a series of failures at the resistance at 655.70 points between January and February 2011 appears to be relatively deep and could therefore affect a profound dynamic. The previous peaks have not been overflowed, or even met, which encourages a degree of caution regarding the configuration of the Index. We’re neutral in the medium-term.....
Day By Day – Indipendent Research
|2 months Opinion||NEUTRAL|
|2 weeks Opinion||POSITIVE|
|Resistances||626 / 655,7 pts|
|Supports||610,8 / 592,2 pts|
Anticipation : In the shorter-term, prices perform a bullish acceleration due to a bearish excess performed below the support at 569.40 points. This strong momentum has allowed for the overflow of the levels at 592.20 points and 610.80 points. The pull- back towards the last one, now strengthened by the support and 100-day moving average (just reinstated), should allow for the overflow of the resistance at 626 points and give rise to a new acceleration phase. We are positive in the short-term and target a rallying towards the resistance at 655.70 points; the previous peaks. We set the invalidation threshold for this positive scenario slightly below the support at 610.80 points.
|Traker’s Name||Leverage||Expense ratio|
|AMUNDI ETF MSCI EUROPE MATERIALS||x1||0,25%|
|ETFX STOXX 600 Basic Resources Fund||x1||0,30%|
|Lyxor ETF Stoxx Europe 600 Basic Resources||x1||0,30%|
|SPDR MSCI Europe Materials ETF||x1||0,30%|
* A leverage of 1 means that the ETF/Tracker has the same performance as the underlying index. A leverage of 2 indicates that the ETF/Tracker will have twice the performance of the underlying index. A leverage of -1 indicates that the ETF/Tracker will perform opposite that of the index: it will rise while the index falls, and vice versa.
This publication is solely intended as information and does not constitute any investment advice or an offer, solicitation or recommendation to acquire or dispose of any investment or to engage in any transaction. Althoughthis publicationis issued in good faith, no representation or warranty, express or implied, is or willbe made and no responsibility or liability is or willbe accepted by NYSE Euronext or by any of its officers, employees or agents in relation to the accuracy or completeness of this publicationand any such liability is expressly disclaimed.No information set out or referred to in this publicationshall form the basis of any contract. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by NYSE Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. NYSE Euronext encourages you to reach your own opinion as to whether investments are appropriate or relevant and recommends you not to make any decisions on the basis of the information contained in this publication before checking it, as you will bear full responsibility for any use that you make of it. Persons wishingto trade products available on NYSE Euronextmarkets or wishingto offer such products to third parties are advised, before doing so, to check their legal and regulatory position in the relevant territory and to understand the related risks. All proprietary rights and interest in or connected with this publicationare vested in NYSE Euronext.No part of it may be redistributed or reproduced in any form or by any means or used to make any derivative work (such as translation, transformation, or adaptation) without the prior written permission of NYSE Euronext. NYSE Euronext refers to NYSE Euronext and its affiliates and references to NYSE Euronext in this publication include each and any such company as the context dictates. NYSE EuronextSM, Euronext®, trackers®, are registered marks of NYSE Euronext.
Source: ETFWorld – Day By Day – Indipendent Research